Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.
Also called NCT02294994
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,000 participants
- Registry
-
NCT02294994
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02294994. Randomized; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- tirofiban
- Lead sponsor
- Second Hospital of Jilin University
Record details
- Record id
cardio:ct-nct02294994- Content hash
b8fda25e981c504a97f795a0aa580be2c3d577919436e1d47ed718d3ad3c25e9